Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Colorectal Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Thyroid Nodule 1Stomach Neoplasms 1Postoperative Complications 1Obesity 1Lymphoma, T-Cell 1Intermittent Fasting 1Hypothyroidism 1Hyperthyroidism 1Goiter 1Endometrial Neoplasms 1Diabetes Mellitus 1Breast Neoplasms 1

Interventions

spartalizumab 1liposomal doxorubicin 1Salvia hispanica seed extract 1Rituximab 1Prednisone 1Methotrexate 1Gemcitabine 1Dexamethasone 1Clinical Protocols 1Cisplatin 1Cholecalciferol 1Azacitidine 1Asparaginase 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, T-Cell × Clinical Protocols × Clear all
NCT05772728 2023-03-16

Chidamide Combined With Azacitidine and Mitoxantrone Liposome in the Treatment of Relapsed/Refractory (nTFHL)

The First Affiliated Hospital with Nanjing Medical University

Phase NA Unknown
23 enrolled
Lymphoid

Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡